Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,780,347 papers from all fields of science
Search
Sign In
Create Free Account
phosphoserine binding
Interacting selectively and non-covalently with a phosphorylated serine residue within a protein. [GOC:ai]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
phosphoserine/phosphothreonine binding
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Characterization of SMG7 14-3-3-like domain reveals phosphoserine binding-independent regulation of p53 and UPF1
Lauren E. Cowen
,
Hongwei Luo
,
Yi Tang
Scientific Reports
2019
Corpus ID: 202557284
The 14-3-3-related protein SMG7 plays critical roles in regulation of DNA damage response and nonsense-mediated mRNA decay (NMD…
Expand
2006
2006
Structural bioinformatics Detection of a tandem BRCT in Nbs 1 and Xrs 2 with functional implications in the DNA damage response
Emmanuelle Becker
,
V. Meyer
,
Hocine Madaoui
,
R. Guérois
2006
Corpus ID: 155094292
Motivation: Human Nbs1 and its homolog Xrs2 in Saccharomyces cerevisiae are part of the conserved MRN complex (MRX in yeast…
Expand
2005
2005
The shear stress of keeping arteries clear
D. Harrison
Nature Network Boston
2005
Corpus ID: 10228592
The force exerted by blood as it flows through the vessels influences the development of atherosclerosis. An understanding of how…
Expand
Highly Cited
2002
Highly Cited
2002
Identification of 14-3-3ζ as a Protein Kinase B/Akt Substrate*
D. Powell
,
M. Rane
,
Qingdan Chen
,
Saurabh Singh
,
K. Mcleish
Journal of Biological Chemistry
2002
Corpus ID: 7848608
Protein kinase B/Akt (PKB/Akt) is a member of the ACG kinase family, which also includes protein kinase C, that phosphorylates a…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE